CCL5 and neoplasm: Cxcr3 and Ccr5, the receptors for CXCL10 and CCL5, were broadly expressed on tumor-infiltrating lymphocytes, including regulatory T cells (Treg), gamma-delta (γδ) T cells, and NK cells (Supplementary Fig. 4a).